Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01471314
Other study ID # H-C-2008-089
Secondary ID
Status Recruiting
Phase N/A
First received November 10, 2011
Last updated August 28, 2012

Study information

Verified date August 2012
Source Glostrup University Hospital, Copenhagen
Contact Faisal Amin, MD, PhD student
Phone +4538633066
Email famoam01@regionh.dk
Is FDA regulated No
Health authority Denmark: The Danish National Committee on Biomedical Research Ethics
Study type Observational

Clinical Trial Summary

The purpose of this study is to examine migraineurs during spontaneous migraine attacks without aura, using high resolution magnetic resonance imaging (MRI), to study following:

- Changes in resting state blood-oxygenation-level-dependent-signal (BOLD-signal) using functional MRI (fMRI).

- Changes in circumferences of intra- and extracranial arteries using MR-angiography (MRA).

- Changes in regional and global cerebral blood flow (CBF) using the arterial spin labeling (ASL) method.

Moreover to perform diffusion tensor imaging (DTI) scans during spontaneous migraine attacks.

The migraine specific drug sumatriptan will be given to relieve pain and the effect will be registered using MRA and fMRI if possible.


Recruitment information / eligibility

Status Recruiting
Enrollment 0
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Migraine without aura according to IHS criteria.

Exclusion Criteria:

- Other primary headaches.

- Tension-type headache more than 5 days/month.

- Use of anti-pain medication before the scanning on the examination day.

- Pregnant or nursing women.

- Contraindication for MR scan.

- Anamnestic or clinical signs of cardiovascular or cerebrovascular disease, unregulated psychiatric disease or drug misuse.

- Other clinical conditions assessed by the examining doctor.

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Intervention

Behavioral:
Headache day versus non-headache day


Locations

Country Name City State
Denmark Glostrup Hospital, Faculty of Health Sciences, University of Copenhagen Glostrup

Sponsors (2)

Lead Sponsor Collaborator
Glostrup University Hospital, Copenhagen Leiden University Medical Center

Country where clinical trial is conducted

Denmark,